DE2128461A1 - Pharmazeutisches Präparat - Google Patents

Pharmazeutisches Präparat

Info

Publication number
DE2128461A1
DE2128461A1 DE19712128461 DE2128461A DE2128461A1 DE 2128461 A1 DE2128461 A1 DE 2128461A1 DE 19712128461 DE19712128461 DE 19712128461 DE 2128461 A DE2128461 A DE 2128461A DE 2128461 A1 DE2128461 A1 DE 2128461A1
Authority
DE
Germany
Prior art keywords
tablet
weight
dopa
polyvinylpyrrolidone
tablets
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19712128461
Other languages
German (de)
English (en)
Inventor
Prabhakar Ranchhordas Nanuet N Y Katz Gilbert Boonton N J Sheth, (V St A)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of DE2128461A1 publication Critical patent/DE2128461A1/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
DE19712128461 1970-06-10 1971-06-08 Pharmazeutisches Präparat Pending DE2128461A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4524470A 1970-06-10 1970-06-10

Publications (1)

Publication Number Publication Date
DE2128461A1 true DE2128461A1 (de) 1971-12-16

Family

ID=21936793

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19712128461 Pending DE2128461A1 (de) 1970-06-10 1971-06-08 Pharmazeutisches Präparat

Country Status (8)

Country Link
US (1) US3632778A (fr)
BE (1) BE768269A (fr)
DE (1) DE2128461A1 (fr)
DK (1) DK126236B (fr)
ES (1) ES392066A1 (fr)
FR (1) FR2100742B1 (fr)
GB (1) GB1296505A (fr)
NL (1) NL7107643A (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0070178A2 (fr) * 1981-07-13 1983-01-19 E.R. Squibb & Sons, Inc. Nouvelles formulations du bendrofluméthiazide
EP0275468A1 (fr) * 1986-12-20 1988-07-27 Roche Diagnostics GmbH Compositions pharmaceutiques contenant du clodronate et leur procédé de préparation

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2246013A1 (de) * 1972-09-20 1974-03-28 Boehringer Mannheim Gmbh Verfahren zur herstellung von poroesen tabletten
US4017636A (en) * 1973-10-23 1977-04-12 Abbott Laboratories Esters of γ-glutamyl amide of dopamine
US4209513A (en) * 1974-02-14 1980-06-24 Burroughs Wellcome Co. Tablet formulation
DE2513940A1 (de) * 1975-03-29 1976-10-14 Merck Patent Gmbh Pharmazeutische zubereitung
US4097606A (en) * 1975-10-08 1978-06-27 Bristol-Myers Company APAP Tablet containing an alkali metal carboxymethylated starch and processes for manufacturing same
US4143129A (en) * 1975-10-11 1979-03-06 Lilly Industries Limited Cephalexin tablets
DE2551446B2 (de) * 1975-11-15 1977-09-15 Karl Werner Schlüter GmbH, 2000 Ham burg Verfahren zur herstellung von suppositorien
JPS5332111A (en) * 1976-09-07 1978-03-27 Asahi Chem Ind Co Ltd Composition for tablet
DE2845326C2 (de) * 1978-10-18 1985-05-23 Beiersdorf Ag, 2000 Hamburg Verwendung einer spezifischen mikrodispersen, amorphen, porösen Kieselsäure zur Herstellung von Digoxin enthaltenden Tabletten mit stark beschleunigter Wirkstoff-Freisetzung
US4195078A (en) * 1979-03-09 1980-03-25 Eli Lilly And Company Nabilone granulation
US4264573A (en) * 1979-05-21 1981-04-28 Rowell Laboratories, Inc. Pharmaceutical formulation for slow release via controlled surface erosion
US4547358A (en) * 1980-05-06 1985-10-15 Mead Johnson & Company Sustained release tablet containing at least 95 percent theophylline
US4465660A (en) * 1981-04-01 1984-08-14 Mead Johnson & Company Sustained release tablet containing at least 95 percent theophylline
JPS5839618A (ja) * 1981-09-04 1983-03-08 Chugai Pharmaceut Co Ltd 持続性積層錠剤
CH652025A5 (de) * 1981-09-14 1985-10-31 Hoffmann La Roche Pharmazeutisches praeparat.
US4736527A (en) * 1982-12-13 1988-04-12 Konishiroku Photo Industry Co., Ltd. Apparatus for the heat treatment of powdery material
HU209564B (en) * 1991-01-30 1994-07-28 Egyt Gyogyszervegyeszeti Gyar Process for producing rapide tablets containing levodopa and carbidopa
JP6679578B2 (ja) * 2014-05-29 2020-04-15 ノバルティス アーゲー セリチニブ製剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3133863A (en) * 1961-03-10 1964-05-19 Strong Cobb Arner Inc Sustained release therapeutic tablet compositions comprising organic solvent-gelled gums
US3458622A (en) * 1967-04-07 1969-07-29 Squibb & Sons Inc Controlled release tablet
US3557292A (en) * 1968-08-16 1971-01-19 Hoffmann La Roche Compositions and methods for treating parkinson's disease with combinations of l-3,4-dihydroxyphenylalanine and a hydrazine

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0070178A2 (fr) * 1981-07-13 1983-01-19 E.R. Squibb & Sons, Inc. Nouvelles formulations du bendrofluméthiazide
EP0070178A3 (fr) * 1981-07-13 1984-04-25 E.R. Squibb & Sons, Inc. Nouvelles formulations du bendrofluméthiazide
EP0275468A1 (fr) * 1986-12-20 1988-07-27 Roche Diagnostics GmbH Compositions pharmaceutiques contenant du clodronate et leur procédé de préparation

Also Published As

Publication number Publication date
FR2100742B1 (fr) 1974-09-06
NL7107643A (fr) 1971-12-14
FR2100742A1 (fr) 1972-03-24
US3632778A (en) 1972-01-04
DK126236B (da) 1973-06-25
GB1296505A (fr) 1972-11-15
ES392066A1 (es) 1974-10-16
BE768269A (fr) 1971-12-09

Similar Documents

Publication Publication Date Title
DE2128461A1 (de) Pharmazeutisches Präparat
DE69431247T2 (de) Oxybutyninformulierungen mit gesteuerter freisetzung
DE69434479T2 (de) Tramadolhaltiges Arzneimittel mit gesteuerter Wirkstoffabgabe
DE69820287T2 (de) Pharmazeutische Zubereitung, die Chlodronat als Wirkstoff und silicifizierte mikrokristalline Cellulose als Exipienten umfasst
DE1228029C2 (de) Verfahren zur Herstellung von Tabletten durch Pressen von Pulvergemischen ohne vorhergehende Granulation
DE69802543T2 (de) Verbesserte multipartikel-tablette mit schnellauflösbarkeit
DE69730834T2 (de) Verfahren zur herstellung von festen oralen dosierungsformen von valsartan
EP2477660B1 (fr) Composition pharmaceutique renfermant les agents actifs metformine et sitagliptine ou vildagliptine
DE69400356T2 (de) Quervernetzte amylose als bindemittel/sprengmittel fuer tabletten
DE2224534B2 (de) Pharmazeutisches praeparat mit langsamer wirkstoffabgabe
DD292837A5 (de) Verfahren zur herstellung von cholestyramin-tabletten
DE1279896B (de) Die Verwendung eines sauren Copolymerisates zur Herstellung von Tabletten mit verlaengerter Wirkstoffabgabe
DE3314003A1 (de) Teilbare tablette mit verzoegerter wirkstofffreigabe und verfahren zu deren herstellung
DE69814850T2 (de) Paracetamol enthaltende schlickbare tablette
EP0250648B1 (fr) Préparation pharmaceutique pour la libération retardée de l'ibuprofène
DE1467781A1 (de) Verfahren zur Herstellung von Dragees mit verlaengerter Wirkstofffreigabe
EP0759296A1 (fr) Composition pharmaceutique de tramadol ou d'un sel de tramadol à délitement rapide
CH656535A5 (en) Process for the production of stable pharmaceutical tablets which disintegrate rapidly in water
DE69205579T2 (de) Virushemmende pharmazeutische zubereitungen zur vaginalen verabreichung.
DE1907546A1 (de) Schnell zerfallende feste Dosierungseinheiten
DE3150557C2 (fr)
DE1195012B (de) Verfahren zur Herstellung eines geformten Koerpers zur Abgabe therapeutisch wirksamer Stoffe
DE2446058A1 (de) Galenische zubereitung fuer die allopurinol-dauertherapie
DE2425764A1 (de) Tabletten
DE2514982A1 (de) Tabletten und verfahren zu ihrer herstellung